GeneAssess' Seed VC Round

GeneAssess raised a round of funding on June 18, 2012. Investors include Foundation Venture Capital Group.

GeneAssess is a biotechnology company developing FRY, a predictive biomarker for breast and other cancers to detect genetic mutations in at-risk populations.…

Articles about GeneAssess' Seed VC Round: